High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
about
AcromegalyCraniopharyngiomaPasireotide: a novel treatment for patients with acromegalyPituitary adenomas: historical perspective, surgical management and future directionsSporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literatureThe molecular pathogenesis of pituitary adenomas: an updateThe risks of overlooking the diagnosis of secreting pituitary adenomasEpidemiology of acromegaly: review of population studies.Pituitary incidentaloma: an endocrine society clinical practice guideline.The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysisIntraoperative handheld optical coherence tomography forward-viewing probe: physical performance and preliminary animal imagingLanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications.Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment.Familial isolated pituitary adenomas: from genetics to therapy.Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach.Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes.Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patientsEnhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levelsGenetically engineered mouse models of pituitary tumorsAdverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care populationDownregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.Early prediction of long-term response to cabergoline in patients with macroprolactinomasStudying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.Geographical information system (GIS) as a new tool to evaluate epidemiology based on spatial analysis and clinical outcomes in acromegaly.Surgical management of acromegaly in a resource-challenged environment.Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.High prevalence of metabolic syndrome features in patients previously treated for nonfunctioning pituitary macroadenomaSilent corticotroph adenomas.The marine metabolite SZ-685C induces apoptosis in primary human nonfunctioning pituitary adenoma cells by inhibition of the Akt pathway in vitroPreoperative Lateralization Modalities for Cushing Disease: Is Dynamic Magnetic Resonance Imaging or Cavernous Sinus Sampling More Predictive of Intraoperative Findings?Geographic-Related Differences of Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern EuropeBody Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls.Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina.Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
P2860
Q21202912-EF4AA67C-15E1-48A5-BC67-32A75C92F189Q21203013-69F7B769-3888-43C6-B6E1-376FD5F34187Q26774437-B07F7483-FD0A-4B69-83CE-2538EB284BEAQ26779749-13E2C001-C869-41F1-821B-4CE2F8F61605Q26825834-0D5FAF53-F75E-4D49-9796-08803B945466Q26830047-DEED584F-2AB1-4FB7-8C56-F2DF7200178EQ28076665-8AFCF2D2-BF47-4A8B-BAAB-EDC55A6C5297Q30244550-835BA76A-48F5-42CB-B492-F7C40651FEB0Q30353104-5DE89688-6988-4BDA-A22E-874A8BA70497Q30382505-61B986E2-B2D9-40E5-8E6D-5EAA1FCD99F9Q30466362-4B678CFD-767C-4DED-BFC6-5592B231947CQ30585813-F8D60512-C48F-4AF4-A71C-62E9EEA02D4FQ30987978-6C553814-EF4C-4ACC-ABE1-0D8A447A15FDQ33579615-B5B8877A-F142-4E87-9F32-2361AD25E6A8Q33654893-A322CB69-EFF4-4915-98FB-0253AB77A654Q33713409-9E2BD034-F823-47CF-8AEE-FB769A7B4B96Q33721266-0D98746F-5282-42EC-93D5-EE15C6CBB925Q33751380-94FC6585-680C-4423-BDA1-853F95205159Q33772673-0D295518-7EA7-4BAD-B483-8A9BDA324E21Q33864414-D23F3411-6874-469F-BF99-81E55E206E40Q33896823-21876008-A499-4714-84EC-8FCE4150A858Q33984418-F95E1B24-CAD2-4B90-82DC-35EC165B9A53Q34031924-16F195CB-F242-442E-9418-8B3DEC126614Q34237969-5A1A227B-0E25-41E2-87B0-E0A4CA5AD76CQ34318860-C9A89680-C4DF-4AF8-9CC5-C1610FE8D7DEQ34478467-6C0AE62A-E7E9-4386-A0B3-B0AA3E5E840AQ34508504-45AD0A61-58A3-47C9-87E5-DEB46C2FE584Q34630270-C13293DF-2EDD-4555-9DE7-A5B9C930190DQ34979883-8A933EC1-64E9-4CB2-AA08-2968578AE690Q35041686-AE54977C-9999-4DE9-B771-803F5F35C51DQ35048001-97F746D0-AD28-4263-9F0B-729DB5C8DBFCQ35096827-E0CE9A91-60EF-4855-BFBC-96572F68B20CQ35114788-5AFBD5E3-EA5B-4B51-B4B1-69DB88474D0DQ35224340-91CCF612-564B-4D26-AFB2-E2474A31894DQ35228260-EED39CE4-DEE1-42CB-8915-8E090127BC0FQ35611261-6585F343-57FE-413E-9A39-A8D0FF2C448EQ35640741-FE087EC2-3038-4F65-AE4C-73B12388E97AQ35675855-3337EA1E-13B5-4512-AA3F-CBF0467FCCBFQ35708559-08264387-4FAA-4244-AD3B-C0629616B31BQ35748977-BF8AEC27-928F-4EAC-8B7D-734AA4B05A50
P2860
High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High prevalence of pituitary a ...... he province of Liege, Belgium.
@ast
High prevalence of pituitary a ...... he province of Liege, Belgium.
@en
High prevalence of pituitary a ...... he province of Liege, Belgium.
@nl
type
label
High prevalence of pituitary a ...... he province of Liege, Belgium.
@ast
High prevalence of pituitary a ...... he province of Liege, Belgium.
@en
High prevalence of pituitary a ...... he province of Liege, Belgium.
@nl
prefLabel
High prevalence of pituitary a ...... he province of Liege, Belgium.
@ast
High prevalence of pituitary a ...... he province of Liege, Belgium.
@en
High prevalence of pituitary a ...... he province of Liege, Belgium.
@nl
P2093
P356
P1476
High prevalence of pituitary a ...... he province of Liege, Belgium.
@en
P2093
Albert Beckers
Anastasia Dempegioti
Christelle Adam
Maria A Tichomirowa
Martine Rixhon
P304
P356
10.1210/JC.2006-1668
P407
P577
2006-09-12T00:00:00Z